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High-dosechemotherapywithautologousperipheralblood
stem cell support for recurrent primary AFP-producing
intracranial germinoma
HochdosischemotherapiemitautologemStammzellsupportfürPatienten
mit AFP-produzierendem Germinom im Rezidiv
Abstract
We report of a 34-year old man with second intracranial relapse of a
suprasellargerminoma.Despiteofextensivepretreatmentwithradiation
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sequential high-dose chemotherapy followed by transfusion of autolo-
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patient achieved a complete remission after high dose chemotherapy
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whichlastedfor13months.Subsequently,hedevelopedathirdrelapse
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Zusammenfassung
Wirberichtenübereinen34JahrealtenPatientenmitzweitemintrakra-
niellemRezidiv eines suprasellärenGerminoms.Trotz intensiver Vorbe-
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handlung mit Bestrahlung und konventioneller Chemotherapie kam es
zum Rezidiv und der Patient wurde mit sequentieller Hochdosischemo-
therapie mit autologem Stammzellensupport behandelt. Während der 2 Medizinische Abteilung II, St.
Vincentiuskrankenhäuser,
Karlsruhe, Germany
HochdosischemotherapiekameszueinerrefraktärenEntgleisungeiner
Pinealdrüsen-Insuffizienz. Der Patient erreichte eine komplette Remis-
sionnachHochdosischemotherapie,diefür13Monateanhielt.Erstarb
nach diesem Zeitraum im Rahmen des dritten Rezidivs.
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Introduction
Tumors of the pineal gland are rare accounting for 0.4 -
1% of all primary tumors of the brain [1]. Different tumor
types are found in the pineal region: tumors that derive
from germ cells (germinomas and "non-germinomatous"
germ cell tumors like embryonic carcinomas and terato-
mas), from parenchymal cells (pinealoblastomas and
pineocytomas), and from glial cells are encountered as
well as lesions that represent non neoplastic cysts [2].
Inallseriesgermcelltumorsrepresentthemostcommon
histology (60%) [2]. The peak incidence of germ cell tu-
mors is in the second decade [3]. In contrastto the other
tumors mentioned which have no sex preference, germ
cell tumors are more frequent in men than in women [1].
First symptoms are often neurological signs and com-
plaints caused by an obstructive hydrocephalus with
headache, nausea, and vomiting and/or involvement of
ocular pathways. Determination of histology, tumor
markers in serum and CSF, and extent of disease are
critical for optimal management of pineal region tumors.
Five year survival rates following radiationrange from 44
1/3 German Medical Science 2003, Vol. 1, ISSN 1612-3174
Case Report OPEN ACCESS- 78% and depend on extent of disease, age, radiation
volume and dose to the primary site but primarily on his-
tology [4]. The five year survival of patients with ger-
minoma is 76% as compared with 21% for those with a
"non-germinomatous" germ cell tumor.
Thereisnoestablishedtherapyforrelapsingorrefractory
intracranialgerminoma.Inanalogytogerminomasofthe
testis a higher curability may be expected with high dose
chemotherapy followed by autologous blood stem-cell
retransfusion [5]. For non germinomatous tumors no
guidelines exist with respect to dosage, combination or
sequence of chemotherapy and radiation.
Case presentation
A 25-year old man became symptomatic by diabetes in-
sipidus. Further examination revealed that these symp-
tomswerecausedbyaprimaryAFPproducinggerminoma
of the pineal gland. The initial treatment in 1987 con-
sistedofradiationofthetumorwith30Gywhichresulted
in a complete remission.
Seven years later he developed a first relapse in the an-
teriorsectionofthefirstventriclewithinfiltrationofbrain
parenchyma, and extension to the intradural and extra-
dural lumbosacral spinal canal. The spinal tumor was ir-
radiated with 30 Gy. Immediately after radiation he was
treated with high dose methotrexate 12 g/m² i.v. on day
1 (total dose 20 g). Three weeks later chemotherapy ac-
cording to the PEB-protocol was initiated: cisplatin 20
mg/m² i.v. d1-d5, etoposide 100 mg/m² i.v. d1-d5, and
bleomycin 30 mg i.v. d1, 8, and 15. Four cycles were
administered.Inordertopreventbleomycininducedlung
damage bleomycin was replaced by ifosfamide 1200
mg/m² i.v. twice daily (d1-d5) in two additional cycles.
Thesesix cyclesresulted in a totaldoseof cisplatin1070
mg, etoposide 4800 mg, bleomycin 395 mg, ifosfamide
24.5 g. Staging three weeks after termination of the
chemotherapyshowedacompleteremissionofthebrain
lesion. Residual masses in the spinal areas were inter-
preted as representing most likely a scar. AFP had re-
turned to normal values.
Another 10 months later the patient suffered from a
second relapse localized again in the anterior section of
theventricleatthesamelocationasthefirstrelapseand
additionally in the roof of the left ventricle. The spinal tu-
mors had an equal size compared to prior relapse. The
AFP level at this time was increased up to 69 U/l.
The patient was treated with a high dose chemotherapy
followed by retransfusion of autologous stem cells. Stem
cell harvesting was successful after one cycle according
tothePEI-protocolwithcisplatin25mg/m²i.v.twicedaily
d2-4(totaldose170mg),etoposide100mg/m²i.v.once
daily d1-d5 (total dose 860 mg), and ifosfamide 1.5 g
twice daily i.v. d1-d5 (total dose 13 g). From day 10 the
patient received filgrastim (Neupogen®) 5 µg/kg s.c. for
stem cell mobilisation. The harvest of three apheresis
were enough for performing two cycles of high dose
chemotherapy (>2 x 10
6 CD 34 pos. cells/kg). After
hematologic reconstitution the patient underwent two
cycles of high dose chemotherapy according to the CEI-
protocol (cumulative dose of carboplatin 375 mg/m² i.v.)
twice daily d1-d5 (total dose of two cycles 5000 mg),
etoposide 310 mg/m² i.v. twice daily d1-d5 (total dose
of two cycles 4100 mg), and ifosfamide 2.5 g/m² i. v.
twice daily (total dose of two cycles 33 g) each followed
by reinfusion of autologous peripheral blood stem cells.
The two cycles were completed within 36 days. The pa-
tient remained aplastic (WBC < 1G/l, thrombocytes <20
G/l) for 7 and 9 days, respectively. After treatment AFP
decreased to 9.6 U/ml and the tumor manifestation in
the brain disappeared. Again the lesions in the spinal
areas were constant in size.
The therapy was complicated by a global insufficiency of
the pineal gland. Since first cranial radiation he received
antidiuretic hormones (ADH) applied as a nasal spray.
During the high dose chemotherapy with fluid intakes up
to 4 liter - to prevent cisplatin induced renal damage - his
urine production increased up to 13 liter/24 hours after
therapy. This pattern was refractory under increase of
ADH, and under substitution of mineralocorticoids. The
serum electrolytes remained stable under substitution.
After termination of chemotherapy the urine production
went back to normal. Other endocrinologic functions re-
mained stable during chemotherapy.
The patient remained in stable remission for a period of
13 months until a third relapse. The tumor was then lo-
calized in the roof of the left ventricle and in the brain
stem. This third relapse was complicated by seizures
whichresolvedunderhighdosedexamethasonetherapy.
Because of extensive pretreatment with chemotherapy
the patients underwent cerebral radiation with another
30 Gy, so the total dose to the brain was 60 Gy. Despite
slowreconstitutionoftheperformancestatusthepatient
died one month later at home most likely due to an
electrolyte derailment.
Discussion
Despite of considerable advances in the treatment of
patientswithgermcelltumors,certainpatients,especially
those who relapse after radiation and/or chemotherapy
fare poorly [6] [7]. Guidelines have not yet been defined
for therapy of relapsed and/or refractory germinoma of
the pineal gland. Considering that germ cell tumors of
the pineal gland have biological similarities to germ cell
tumors of the testis, the patient was treated at second
relapse with high dose chemotherapy and stem cell sup-
port in analogy to treatment protocols for systemic germ
cell tumors [5].
Todatetherearenoreportsonadultpatientswithrelapse
ofapinealgerminomatreatedwithhighdosechemother-
apy and stem cell transplantation. Kimura et al reported
of a patient with a primary β-HCG producing cerebral
germinoma who gained a complete remission after high
dose chemotherapy and autologous bone marrow trans-
plantation [8]. Graham et al reported about a heteroge-
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with germ cell tumors) treated with different high dose
chemotherapy regimens followed by autologous marrow
rescue[9]. Both childrenwere alive and had no evidence
ofdisease30and20monthsrespectivelyaftertreatment.
In contrast to the here reported patient both children
were treated with high dose chemotherapy and marrow
rescue as first line treatment because of high risk of re-
currence.
Our patient remained in stable complete remission for
13monthsafterhighdosechemotherapywithautologous
stem cell support. Most likely due to the high curability
rateofintracerebralgerminomawithconventionaltherapy
and/or radiation there are no published data of survival
or disease free survival times after tumor recurrence for
conventional therapy. However, in the most cases the
duration of second or third remission is shorter than the
firstremission.Thethirdremissiongainedafterhigh-dose
chemotherapy and stem cell transplantation had a three
months longer duration than his second remission.
High-dose chemotherapy with autologous stem cell sup-
port is a potentially curative treatment for patients with
relapsed or high risk (metastatic disease) germinomas
of the pineal gland. According to data from other tumor
entities, the response to chemotherapy seems to be the
best prognostic factor.
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